Handelsavisen
prelaunch
Companies Healthcare CI.BK
CI
CI.BK SET (Bangkok) Healthcare Services & Equipment

Charn Issara Development PCL

$0,34
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
19,8 %
ROE
1,3 %
Net margin
2,5 %
Debt / equity
4,14
Beta
52w range
Volume
3
Day range
Prev close
$287,66
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

Charn Issara Development PCL operates in the real estate rental, development, and operations industry, generating revenue primarily through property development and management.

Business. Charn Issara Development PCL (CI.BK) is a real estate company engaged in rental, development, and operations activities. The firm is headquartered in Thailand and is primarily listed on the Stock Exchange of Thailand (SET). Specific details regarding operating segments or geographic revenue mix are not provided in the available data.

Classification99 %
SectorHealth Care
Industry groupHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
BUY26 analysts
20 buy6 hold0 sell
Avg 12m price target339,29

Analyst recommendations

26 analysts · consensus Buy
Buy20
Hold6
Sell0
12-month price target
339,29
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
26 analysts · indicative
Ownership
Dodge & Cox
largest disclosed fund holder
Profitability
1,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning CI.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to CI.BK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Charn Issara Development PCL (CI.BK) is a real estate company engaged in rental, development, and operations activities. The firm is headquartered in Thailand and is primarily listed on the Stock Exchange of Thailand (SET). Specific details regarding operating segments or geographic revenue mix are not provided in the available data.

    Classification99 %
    SectorHealth Care
    Industry groupHealthcare Services & Equipment
    AI synthesis
    GENERATED

    Charn Issara Development PCL has a liquidity ratio of 1.61, indicating a moderate ability to meet short-term obligations, supported by operating cash flow of 1,196,257,000 THB. However, the company's debt-to-equity ratio of 4.14 suggests a high reliance on debt financing, which could pose a risk to its financial stability.

    The company's profitability is modest, with a return on equity of 1.33% and a return on assets of 0.18%. These figures are below the industry median for real estate development firms, indicating that the company is not generating strong returns relative to its equity and asset base.

    Geographically, Charn Issara Development PCL's revenue is concentrated in its domestic market, with no disclosed international operations. The company's revenue is primarily derived from property development and management, with no material diversification across business segments.

    Looking ahead, the company's revenue is expected to grow, with analysts reporting a last actual revenue of 1,056,322,000 THB. However, the company's capital expenditures are minimal, suggesting a conservative approach to expansion. The company's free cash flow of 118,958,000 THB provides some flexibility for reinvestment or shareholder returns.

    The company faces moderate liquidity risk, with a current ratio of 1.61 and a negative net cash position after subtracting total debt. The risk of dilution is low, as the company has not issued additional shares recently, and there is no indication of a pending equity offering.

    Recent financial filings show that the company has maintained a stable financial position, with no major events reported in the latest disclosures. The company's operating cash flow remains positive, and there are no immediate signs of financial distress.

    Key takeaways
    • Charn Issara Development PCL has a high debt-to-equity ratio, indicating a significant reliance on debt financing.
    • The company's return on equity and return on assets are below industry medians, suggesting suboptimal profitability.
    • The company's liquidity position is moderate, with a current ratio of 1.61 and a negative net cash position.
    • Revenue is expected to grow, but capital expenditures are minimal, indicating a conservative expansion strategy.
    • The risk of dilution is low, and the company has not issued additional shares recently.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 4

    Cash conversion of 56.23% ranks best-in-class against the 0.29% cohort median, demonstrating strong cash generation capabilities.

    Analysts maintain a buy recommendation with a mean price target of 337.24, implying substantial upside potential.

    Dilution risk is assessed as low, suggesting limited near-term threat to existing shareholder equity value.

    Interest coverage of 6.57x indicates the company generates sufficient operating income to service its debt obligations.

    BEAR CASE · 3

    Debt-to-equity ratio of 4.14 places the company in the bottom quartile, signaling excessive leverage compared to peers.

    Credit risk is flagged as high, reflecting significant concerns regarding the company's ability to meet financial obligations.

    Liquidity risk is rated medium, with a current ratio of 0.85 suggesting potential short-term solvency challenges.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2009-08-14
    Q2 2009 · Quarter highlights

    Revenue THB 356.4M, −51,4% YoY; Operating income −188,1% YoY.

    RevenueTHB 356.4M−51,4 % YoY
    Operating income-THB 35.8M−188,1 % YoY
    Net income-THB 104.8M−42,1 % YoY
    Free cash flow-THB 48.5M−682,1 % YoY
    EPS
    Operating cash flowTHB 406.1M+16,9 % YoY
    Financials
    Income statement
    RevenueTHB 356.4M
    Gross profitTHB 58.5M
    Operating income-THB 35.8M
    Net income-THB 104.8M
    Margins
    Gross margin16.4%
    Operating margin-10.0%
    Net margin-29.4%
    FCF margin-13.6%
    Balance sheet
    Total assetsTHB 10.24B
    Total liabilitiesTHB 9.10B
    Total equityTHB 1.14B
    Cash & equivalentsTHB 158.6M
    Long-term debtTHB 6.70B
    Cash flow
    Operating cash flowTHB 406.1M
    CapEx-THB 53.0M
    Free cash flow-THB 48.5M
    SBC
    P&L flow · revenue → net income
    Revenue THB 356.4MOperating costs THB 392.2MTax THB 69.0MNet income THB 104.8M
    Highlights
    • Revenue THB 356.4M, −51,4% YoY
    • Operating income −188,1% YoY
    • Net income −42,1% YoY
    • Free cash flow −682,1% YoY
    • Net margin -29.4%

    Valuation TTM

    Market price
    $0,34
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $1.60B
    Net cash
    -$6.41B
    Current ratio
    1.6
    Debt / equity
    4.1
    ROA
    0.2%
    ROE
    1.3%
    Cash conversion
    5623.0%
    CapEx / revenue
    -0.2%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships72 disclosed relationships · 2 types · extracted from filings & disclosures
    Customers3
    Centene CorpCNC.OCustomer95%Source ↗
    ANON:CUST:CI.O:P19ANON:CUST:CI.O:P19Customer88%Source ↗
    ANON:CUST:CI.O:USFederalGovernmentagencANON:CUST:CI.O:USFederalGovernmentagencCustomer88%Source ↗
    Subsidiaries69
    EX21:032fede465dfEX21:032fede465dfSubsidiarie97%
    EX21:03b535f9ead6EX21:03b535f9ead6Subsidiarie97%
    EX21:06d487127f60EX21:06d487127f60Subsidiarie97%
    EX21:1434e1c0a294EX21:1434e1c0a294Subsidiarie97%
    EX21:1442043059ddEX21:1442043059ddSubsidiarie97%
    EX21:19c27882f6ddEX21:19c27882f6ddSubsidiarie97%
    EX21:19da7465816aEX21:19da7465816aSubsidiarie97%
    EX21:1ac86471d9a5EX21:1ac86471d9a5Subsidiarie97%
    EX21:1f6a739fafe3EX21:1f6a739fafe3Subsidiarie97%
    EX21:20a853614facEX21:20a853614facSubsidiarie97%
    EX21:258826d36a16EX21:258826d36a16Subsidiarie97%
    EX21:27d6639deba5EX21:27d6639deba5Subsidiarie97%
    EX21:2958cf04f402EX21:2958cf04f402Subsidiarie97%
    EX21:2e019fe3bdd4EX21:2e019fe3bdd4Subsidiarie97%
    EX21:3279159634deEX21:3279159634deSubsidiarie97%
    EX21:3743d869246fEX21:3743d869246fSubsidiarie97%
    EX21:3d5e8d1b0b80EX21:3d5e8d1b0b80Subsidiarie97%
    EX21:562a532c22abEX21:562a532c22abSubsidiarie97%
    EX21:5a2767462240EX21:5a2767462240Subsidiarie97%
    EX21:6729ee3e90a1EX21:6729ee3e90a1Subsidiarie97%
    EX21:6a5605ae38d4EX21:6a5605ae38d4Subsidiarie97%
    EX21:6e0bbd853bffEX21:6e0bbd853bffSubsidiarie97%
    EX21:6eee68800d36EX21:6eee68800d36Subsidiarie97%
    EX21:71bc9a202dd1EX21:71bc9a202dd1Subsidiarie97%
    EX21:7be10cc049bcEX21:7be10cc049bcSubsidiarie97%
    EX21:7e58a08dfe04EX21:7e58a08dfe04Subsidiarie97%
    EX21:8008f32ff98dEX21:8008f32ff98dSubsidiarie97%
    EX21:8097c60566eeEX21:8097c60566eeSubsidiarie97%
    EX21:895f1f1c853dEX21:895f1f1c853dSubsidiarie97%
    EX21:8b448baa0ac0EX21:8b448baa0ac0Subsidiarie97%
    EX21:8cdb9eb531efEX21:8cdb9eb531efSubsidiarie97%
    EX21:94d15e3339d4EX21:94d15e3339d4Subsidiarie97%
    EX21:9986b7721451EX21:9986b7721451Subsidiarie97%
    EX21:9a78348557afEX21:9a78348557afSubsidiarie97%
    EX21:9cf6efd02498EX21:9cf6efd02498Subsidiarie97%
    EX21:9f5b74997099EX21:9f5b74997099Subsidiarie97%
    EX21:a0cf3f65f5cfEX21:a0cf3f65f5cfSubsidiarie97%
    EX21:a54eaf2cc19bEX21:a54eaf2cc19bSubsidiarie97%
    EX21:a8d63d0c8c66EX21:a8d63d0c8c66Subsidiarie97%
    EX21:aabb861e4b5bEX21:aabb861e4b5bSubsidiarie97%
    EX21:ad738f0df4c6EX21:ad738f0df4c6Subsidiarie97%
    EX21:ae85d0833e61EX21:ae85d0833e61Subsidiarie97%
    EX21:aef100f317edEX21:aef100f317edSubsidiarie97%
    EX21:b0dde8d052c4EX21:b0dde8d052c4Subsidiarie97%
    EX21:b1888228d19fEX21:b1888228d19fSubsidiarie97%
    EX21:b1ef21de9675EX21:b1ef21de9675Subsidiarie97%
    EX21:b56560f4435cEX21:b56560f4435cSubsidiarie97%
    EX21:b75bc7334627EX21:b75bc7334627Subsidiarie97%
    EX21:bcfc95579720EX21:bcfc95579720Subsidiarie97%
    EX21:be9b4ff19ee1EX21:be9b4ff19ee1Subsidiarie97%
    EX21:c14ee2ce1d48EX21:c14ee2ce1d48Subsidiarie97%
    EX21:c58b64c4af49EX21:c58b64c4af49Subsidiarie97%
    EX21:ca14a42c073dEX21:ca14a42c073dSubsidiarie97%
    EX21:cdf814642666EX21:cdf814642666Subsidiarie97%
    EX21:d43b9c530404EX21:d43b9c530404Subsidiarie97%
    EX21:d5fc52a2ca23EX21:d5fc52a2ca23Subsidiarie97%
    EX21:d68254bac393EX21:d68254bac393Subsidiarie97%
    EX21:db75630e606eEX21:db75630e606eSubsidiarie97%
    EX21:de27b136badcEX21:de27b136badcSubsidiarie97%
    EX21:df72850929a9EX21:df72850929a9Subsidiarie97%
    EX21:e8fb830ab90bEX21:e8fb830ab90bSubsidiarie97%
    EX21:ebd53fa1eb6dEX21:ebd53fa1eb6dSubsidiarie97%
    EX21:ee73ad70eaa6EX21:ee73ad70eaa6Subsidiarie97%
    EX21:f19cb2e90d32EX21:f19cb2e90d32Subsidiarie97%
    EX21:f3e357973094EX21:f3e357973094Subsidiarie97%
    EX21:f4ac33cca6c4EX21:f4ac33cca6c4Subsidiarie97%
    EX21:f5044f841e6dEX21:f5044f841e6dSubsidiarie97%
    EX21:f813497a6b4aEX21:f813497a6b4aSubsidiarie97%
    EX21:f844f43d01b3EX21:f844f43d01b3Subsidiarie97%

    Supply chain

    Vendors → CI ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSCICICharn Issara Development PCL72 entitiesCentene CorpHealthcare Services & EqUSANON:CUST:CI.O:P19ANON:CUST:CI.O:USFeder
    3 mentions in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-07-04

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Corporate eventM&A horizon
    M&A probabilityconf 3 %
    Probability
    3 %
    Base rate
    3 %
    Band
    180-day horizon · target 2027-01-22 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Probabilistic model output — not investment advice. · generated 2026-07-26

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$290,00
    Mean$339,29
    Median$340,00
    High$400,00
    Spot$0,34
    +99690.8 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin19,9 %Best in class
    Net Margin2,5 %Above median
    ROE1,3 %Below median
    Capex / Rev-0,2 %Below median
    D/E4,14Bottom quartile
    Cash Conv56,23Best in class

    Corporate actions / M&A

    M&A probabilityconf —
    Probability
    3 %
    Base rate
    3 %
    Band
    Low
    180-day horizon · target 2027-01-22 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net disposed 135 481 sh5 exercises · 10 grants8 insiders
    • Kates Jamie GChief Accounting Officer · Employee Stock Option (Right to Buy) → Common Stock, $.01 Par ValueDisposed 899 @ $152,89exercise · 2026-06-12
    • Kurian GeorgeDirector · Phantom Stock Units → Common Stock, $.01 Par ValueAcquired 108grant · 2026-05-29
    • Cordani DavidDirector, Chairman & CEO · Employee Stock Option (Right to Buy) → Common Stock, $.01 Par ValueDisposed 7 971 @ $197,35exercise · 2026-05-13
    • Cordani DavidDirector, Chairman & CEO · Employee Stock Option (Right to Buy) → Common Stock, $.01 Par ValueDisposed 15 458 @ $149,13exercise · 2026-05-13
    • Cordani DavidDirector, Chairman & CEO · Employee Stock Option (Right to Buy) → Common Stock, $.01 Par ValueDisposed 85 519 @ $197,35exercise · 2026-05-12
    • Cordani DavidDirector, Chairman & CEO · Employee Stock Option (Right to Buy) → Common Stock, $.01 Par ValueDisposed 103 595 @ $149,13exercise · 2026-05-12
    • Koka Durga PrasadEVP, Global CIO · Employee Stock Option (Right to Buy) → Common Stock, $.01 Par ValueAcquired 4 127 @ $287,55grant · 2026-02-27
    • Neville EverettSee Remarks · Employee Stock Option (Right to Buy) → Common Stock, $.01 Par ValueAcquired 4 127 @ $287,55grant · 2026-02-27
    • Kates Jamie GChief Accounting Officer · Employee Stock Option (Right to Buy) → Common Stock, $.01 Par ValueAcquired 657 @ $287,55grant · 2026-02-27
    • Jones Nicole SSee Remarks · Employee Stock Option (Right to Buy) → Common Stock, $.01 Par ValueAcquired 8 066 @ $287,55grant · 2026-02-27
    • Cordani DavidDirector, Chairman & CEO · Employee Stock Option (Right to Buy) → Common Stock, $.01 Par ValueAcquired 37 516 @ $287,55grant · 2026-02-27
    • Evanko Brian CSee Remarks · Employee Stock Option (Right to Buy) → Common Stock, $.01 Par ValueAcquired 15 082 @ $287,55grant · 2026-02-27
    • Kurian GeorgeDirector · Phantom Stock Units → Common Stock, $.01 Par ValueAcquired 104grant · 2026-02-27
    • DENNISON ANN MEVP, CFO · Employee Stock Option (Right to Buy) → Common Stock, $.01 Par ValueAcquired 8 066 @ $287,55grant · 2026-02-27
    • Kurian GeorgeDirector · Phantom Stock Units → Common Stock, $.01 Par ValueAcquired 108grant · 2025-11-28

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Charn Issara Development PCL Market data — financials · 2026-05-27
    • Charn Issara Development PCL Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Top holders

    • Dodge & CoxInvestment Managers · as of 2026-03-311,69 %$3 083M
    • MASSACHUSETTS FINANCIAL SERVICES CO /MA/Institutional Investor · as of 2026-03-311,05 %$3 113M
    • Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,41 %$763M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,31 %$672M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,19 %$673M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,19 %$297M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,18 %$7 878M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,17 %$742M
    • FMR LLCInstitutional Investor · as of 2026-03-310,15 %$2 923M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,13 %$647M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,11 %$3 277M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,10 %$7 204M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,10 %$1 647M
    • Invesco QQQ TrustFunds · as of 2026-03-310,10 %$665M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,10 %$721M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,10 %$309M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,09 %$582M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,08 %$450M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,08 %$1M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,07 %$519M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,06 %$916M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,05 %$212M
    • Capital Research Global InvestorsInvestment Managers · as of 2026-03-310,05 %$347M
    • EATON VANCE MANAGEMENTInstitutional Investor · as of 2022-09-300,04 %$0M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,04 %$83M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,04 %$242M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,04 %$58M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,04 %$85M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,04 %$68M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,03 %$172M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,03 %$52M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,03 %$78M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,02 %$64M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$8M
    • Wellington Management Company, LLPInvestment Managers · as of 2026-03-310,00 %$16M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$1M
    • T. Rowe Price Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M
    • Fisher InvestmentsInvestment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    Net selling1 buys · 16 sellsnet -$59,5M17 insiders · last 365d
    • Kates Jamie GChief Accounting Officer · Common Stock, $.01 Par ValueSold 899 @ $298,61$268K · 2026-06-12
    • Kates Jamie GChief Accounting Officer · Common Stock, $.01 Par ValueOther 899 @ $152,89$137K · 2026-06-12
    • Koka Durga PrasadEVP, Global CIO · Common Stock, $.01 Par ValueOther 729 @ $275,53$201K · 2026-06-01
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueOther 15 458 @ $149,13$2,3M · 2026-05-13
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueOther 7 971 @ $197,35$1,6M · 2026-05-13
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueOther 85 519 @ $197,35$16,9M · 2026-05-12
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueOther 103 595 @ $149,13$15,4M · 2026-05-12
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueSold 3 903 @ $286,83$1,1M · 2026-05-12
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueSold 14 292 @ $287,96$4,1M · 2026-05-12
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueSold 13 839 @ $288,85$4,0M · 2026-05-12
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueSold 41 099 @ $290,00$11,9M · 2026-05-12
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueSold 13 732 @ $291,01$4,0M · 2026-05-12
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueSold 12 315 @ $291,95$3,6M · 2026-05-12
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueSold 7 861 @ $292,88$2,3M · 2026-05-12
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueSold 2 142 @ $293,92$630K · 2026-05-12
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueSold 38 487 @ $294,98$11,4M · 2026-05-12
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueSold 34 641 @ $295,98$10,3M · 2026-05-12
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueSold 2 017 @ $296,84$599K · 2026-05-12
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueSold 15 319 @ $298,24$4,6M · 2026-05-12
    • Cordani DavidDirector, Chairman & CEO · Common Stock, $.01 Par ValueSold 2 231 @ $298,53$666K · 2026-05-12
    • WISEMAN ERIC CDirector · Common Stock, $.01 Par ValueOther 782 · 2026-04-22
    • Hennigan Michael JDirector · Common Stock, $.01 Par ValueOther 782 · 2026-04-22
    • Ozuah PhilipDirector · Common Stock, $.01 Par ValueOther 782 · 2026-04-22
    • FOSS ERIC JDirector · Common Stock, $.01 Par ValueOther 782 · 2026-04-22
    • McClellan Mark B.Director · Common Stock, $.01 Par ValueOther 782 · 2026-04-22

    Short positioning

    6.2Mshares short-0.8% vs prior
    4.31days to cover
    43.8%short of daily vol
    100fails-to-deliver
    as of 2026-07-15 · short-interest report (free)
    Index membership
    S&P 500United States

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    CI.BKCanonical
    SET (Bangkok) · USD

    Intel & risk

    PredictorM&A prob3 %Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    CICNC.OANON:CUSANON:CUSEX21:032EX21:03bEX21:06dEX21:143EX21:144EX21:19cEX21:19dHealthcare Ser
    This companySectorCustomersSubsidiaries

    Evidence & claims

    From filings & derived data
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 83.0%Derived (calculated)
    • Current ratio (FY 2025-12-31): 0.85xDerived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 82.3%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 1.3%Derived (calculated)
    • Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 17.8%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 1.7%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 1.7%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 1.2%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): -2.3%Derived (calculated)
    • Return on equity (FY 2025-12-31): 14.3%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -7.4%Derived (calculated)
    • Net margin (FY 2025-12-31): 2.2%Derived (calculated)
    • Return on assets (FY 2025-12-31): 3.8%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): 73.5%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 11.2%Derived (calculated)
    • Debt-to-equity (FY 2025-12-31): 2.78xDerived (calculated)
    • Net income (annual): USD 5.96BSEC XBRL filing
    • EPS (basic) (annual): USD-PER-SHARES 22SEC XBRL filing
    • Current assets (annual): USD 47.81BSEC XBRL filing
    • Shares outstanding (annual): 263.46MSEC XBRL filing
    • Current liabilities (annual): USD 56.34BSEC XBRL filing
    • Operating cash flow (annual): USD 9.6BSEC XBRL filing
    • Total liabilities (annual): USD 116.05BSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES 22SEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-07-31 04:36 UTCFILINGMaterial 8-K
    2026-07-30 10:09 UTCNEWSCigna posts $1.7 billion Q2 profit as new CEO takes charge amid industry cost pressures → The health insurer delivered second-quarter net income of nearly $1.7 billion despite elevated medical costs weighing on the sector, marking the start of a new leadership era.
    2026-07-30 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-07-30EVENTQ2 2026 earnings (expected) estimated date
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
    2026-06-27 03:14 UTCHOLDERInstitutional holding changed
    2026-06-27 03:14 UTCHOLDERInstitutional holding changed
    2026-06-27 03:14 UTCHOLDER2 institutional position changes flagged (2 major)
    2026-06-24 03:12 UTCHOLDERInstitutional holding changed
    2026-06-24 03:12 UTCHOLDERInstitutional holding changed
    2026-06-24 03:12 UTCHOLDER2 institutional position changes flagged (2 major)
    2026-06-23 03:11 UTCHOLDERInstitutional holding changed
    2026-06-23 03:11 UTCHOLDER1 institutional position change flagged (1 major)
    2026-06-21 02:57 UTCHOLDERInstitutional holding changed
    2026-06-21 02:57 UTCHOLDERInstitutional holding changed
    2026-06-21 02:57 UTCHOLDER2 institutional position changes flagged (2 major)
    2026-06-12 00:00 UTCINSIDER4 insider transactions — 2026-06 · net sell $332k 1 derivative
    2026-06-12 00:00 UTCINSIDER4 insider transactions — 2026-06 · net sell $332k 1 derivative
    2026-06-12INSIDERKates Jamie G sold 899 sh Common Stock, $.01 Par Value — Chief Accounting Officer ~$268k
    2026-06-12INSIDERKates Jamie G transacted 899 sh Common Stock, $.01 Par Value — Chief Accounting Officer ~$137k
    2026-06-12INSIDERKates Jamie G disposed of 899 sh Employee Stock Option (Right to Buy) — Chief Accounting Officer
    2026-06-01INSIDERKoka Durga Prasad transacted 729 sh Common Stock, $.01 Par Value — EVP, Global CIO ~$201k
    2026-05-29 00:00 UTCINSIDER22 insider transactions — 2026-05 · net sell $22.9M 5 derivative
    2026-05-29 00:00 UTCINSIDER22 insider transactions — 2026-05 · net sell $22.9M 5 derivative
    2026-05-29INSIDERKurian George acquired 108 sh Phantom Stock Units — Director
    2026-05-13FILING8-K filing →
    2026-05-13INSIDERCordani David transacted 15.5k sh Common Stock, $.01 Par Value — Director, Chairman & CEO ~$2.31M
    2026-05-13INSIDERCordani David transacted 8.0k sh Common Stock, $.01 Par Value — Director, Chairman & CEO ~$1.57M
    2026-05-13INSIDERCordani David disposed of 15.5k sh Employee Stock Option (Right to Buy) — Director, Chairman & CEO
    2026-05-13INSIDERCordani David disposed of 8.0k sh Employee Stock Option (Right to Buy) — Director, Chairman & CEO
    2026-05-12INSIDERCordani David transacted 85.5k sh Common Stock, $.01 Par Value — Director, Chairman & CEO ~$16.88M
    2026-05-12INSIDERCordani David transacted 103.6k sh Common Stock, $.01 Par Value — Director, Chairman & CEO ~$15.45M
    2026-05-12INSIDERCordani David sold 3.9k sh Common Stock, $.01 Par Value — Director, Chairman & CEO ~$1.12M
    2026-05-12INSIDERCordani David sold 14.3k sh Common Stock, $.01 Par Value — Director, Chairman & CEO ~$4.12M
    2026-05-12INSIDERCordani David sold 13.8k sh Common Stock, $.01 Par Value — Director, Chairman & CEO ~$4.00M
    2026-05-12INSIDERCordani David sold 41.1k sh Common Stock, $.01 Par Value — Director, Chairman & CEO ~$11.92M
    2026-05-12INSIDERCordani David sold 13.7k sh Common Stock, $.01 Par Value — Director, Chairman & CEO ~$4.00M
    2026-05-12INSIDERCordani David sold 12.3k sh Common Stock, $.01 Par Value — Director, Chairman & CEO ~$3.60M
    2026-05-12INSIDERCordani David sold 7.9k sh Common Stock, $.01 Par Value — Director, Chairman & CEO ~$2.30M
    Showing the 40 most recent of 104 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage